nodes	percent_of_prediction	percent_of_DWPC	metapath
Ammonium lactate—Ichthyosis acquired—Fluorouracil—pancreatic cancer	0.126	0.126	CcSEcCtD
Ammonium lactate—Ichthyosis—Fluorouracil—pancreatic cancer	0.126	0.126	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.0357	0.0357	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.0309	0.0309	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.0244	0.0244	CcSEcCtD
Ammonium lactate—Skin exfoliation—Tamoxifen—pancreatic cancer	0.0205	0.0205	CcSEcCtD
Ammonium lactate—Skin exfoliation—Erlotinib—pancreatic cancer	0.0203	0.0203	CcSEcCtD
Ammonium lactate—Petechiae—Gemcitabine—pancreatic cancer	0.0179	0.0179	CcSEcCtD
Ammonium lactate—Stinging—Fluorouracil—pancreatic cancer	0.0179	0.0179	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.0176	0.0176	CcSEcCtD
Ammonium lactate—Skin exfoliation—Sunitinib—pancreatic cancer	0.0175	0.0175	CcSEcCtD
Ammonium lactate—Extravasation—Irinotecan—pancreatic cancer	0.0173	0.0173	CcSEcCtD
Ammonium lactate—Extravasation—Gemcitabine—pancreatic cancer	0.0169	0.0169	CcSEcCtD
Ammonium lactate—Extravasation—Fluorouracil—pancreatic cancer	0.0166	0.0166	CcSEcCtD
Ammonium lactate—Eczema—Sunitinib—pancreatic cancer	0.0148	0.0148	CcSEcCtD
Ammonium lactate—Dry skin—Erlotinib—pancreatic cancer	0.0141	0.0141	CcSEcCtD
Ammonium lactate—Skin exfoliation—Gemcitabine—pancreatic cancer	0.0141	0.0141	CcSEcCtD
Ammonium lactate—Venous thrombosis—Epirubicin—pancreatic cancer	0.0131	0.0131	CcSEcCtD
Ammonium lactate—Dry skin—Sunitinib—pancreatic cancer	0.0122	0.0122	CcSEcCtD
Ammonium lactate—Venous thrombosis—Doxorubicin—pancreatic cancer	0.0121	0.0121	CcSEcCtD
Ammonium lactate—Extravasation—Docetaxel—pancreatic cancer	0.012	0.012	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.0119	0.0119	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.011	0.011	CcSEcCtD
Ammonium lactate—Skin exfoliation—Docetaxel—pancreatic cancer	0.00999	0.00999	CcSEcCtD
Ammonium lactate—Dry skin—Fluorouracil—pancreatic cancer	0.00964	0.00964	CcSEcCtD
Ammonium lactate—Erythema—Tamoxifen—pancreatic cancer	0.00938	0.00938	CcSEcCtD
Ammonium lactate—Erythema—Erlotinib—pancreatic cancer	0.00928	0.00928	CcSEcCtD
Ammonium lactate—Phlebitis—Docetaxel—pancreatic cancer	0.00881	0.00881	CcSEcCtD
Ammonium lactate—Stinging—Epirubicin—pancreatic cancer	0.00871	0.00871	CcSEcCtD
Ammonium lactate—Petechiae—Epirubicin—pancreatic cancer	0.00858	0.00858	CcSEcCtD
Ammonium lactate—Extravasation—Epirubicin—pancreatic cancer	0.00809	0.00809	CcSEcCtD
Ammonium lactate—Stinging—Doxorubicin—pancreatic cancer	0.00806	0.00806	CcSEcCtD
Ammonium lactate—Erythema—Sunitinib—pancreatic cancer	0.00803	0.00803	CcSEcCtD
Ammonium lactate—Petechiae—Doxorubicin—pancreatic cancer	0.00794	0.00794	CcSEcCtD
Ammonium lactate—Infection—Tamoxifen—pancreatic cancer	0.0076	0.0076	CcSEcCtD
Ammonium lactate—Infection—Erlotinib—pancreatic cancer	0.00752	0.00752	CcSEcCtD
Ammonium lactate—Extravasation—Doxorubicin—pancreatic cancer	0.00748	0.00748	CcSEcCtD
Ammonium lactate—Skin disorder—Erlotinib—pancreatic cancer	0.00735	0.00735	CcSEcCtD
Ammonium lactate—Dry skin—Docetaxel—pancreatic cancer	0.00696	0.00696	CcSEcCtD
Ammonium lactate—Skin exfoliation—Epirubicin—pancreatic cancer	0.00674	0.00674	CcSEcCtD
Ammonium lactate—Pain—Tamoxifen—pancreatic cancer	0.00654	0.00654	CcSEcCtD
Ammonium lactate—Infection—Sunitinib—pancreatic cancer	0.00651	0.00651	CcSEcCtD
Ammonium lactate—Pain—Erlotinib—pancreatic cancer	0.00647	0.00647	CcSEcCtD
Ammonium lactate—Erythema—Gemcitabine—pancreatic cancer	0.00644	0.00644	CcSEcCtD
Ammonium lactate—Skin disorder—Sunitinib—pancreatic cancer	0.00637	0.00637	CcSEcCtD
Ammonium lactate—Erythema—Fluorouracil—pancreatic cancer	0.00634	0.00634	CcSEcCtD
Ammonium lactate—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00623	0.00623	CcSEcCtD
Ammonium lactate—Body temperature increased—Erlotinib—pancreatic cancer	0.00599	0.00599	CcSEcCtD
Ammonium lactate—Phlebitis—Epirubicin—pancreatic cancer	0.00594	0.00594	CcSEcCtD
Ammonium lactate—Eczema—Epirubicin—pancreatic cancer	0.0057	0.0057	CcSEcCtD
Ammonium lactate—Pain—Sunitinib—pancreatic cancer	0.0056	0.0056	CcSEcCtD
Ammonium lactate—Phlebitis—Doxorubicin—pancreatic cancer	0.0055	0.0055	CcSEcCtD
Ammonium lactate—Infection—Irinotecan—pancreatic cancer	0.00536	0.00536	CcSEcCtD
Ammonium lactate—Eczema—Doxorubicin—pancreatic cancer	0.00527	0.00527	CcSEcCtD
Ammonium lactate—Infection—Gemcitabine—pancreatic cancer	0.00522	0.00522	CcSEcCtD
Ammonium lactate—Body temperature increased—Sunitinib—pancreatic cancer	0.00518	0.00518	CcSEcCtD
Ammonium lactate—Infection—Fluorouracil—pancreatic cancer	0.00514	0.00514	CcSEcCtD
Ammonium lactate—Skin disorder—Gemcitabine—pancreatic cancer	0.00511	0.00511	CcSEcCtD
Ammonium lactate—Rash—Tamoxifen—pancreatic cancer	0.00482	0.00482	CcSEcCtD
Ammonium lactate—Dermatitis—Tamoxifen—pancreatic cancer	0.00482	0.00482	CcSEcCtD
Ammonium lactate—Rash—Erlotinib—pancreatic cancer	0.00477	0.00477	CcSEcCtD
Ammonium lactate—Dermatitis—Erlotinib—pancreatic cancer	0.00477	0.00477	CcSEcCtD
Ammonium lactate—Dry skin—Epirubicin—pancreatic cancer	0.00469	0.00469	CcSEcCtD
Ammonium lactate—Pain—Irinotecan—pancreatic cancer	0.00462	0.00462	CcSEcCtD
Ammonium lactate—Erythema—Docetaxel—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Ammonium lactate—Pain—Gemcitabine—pancreatic cancer	0.0045	0.0045	CcSEcCtD
Ammonium lactate—Pain—Fluorouracil—pancreatic cancer	0.00442	0.00442	CcSEcCtD
Ammonium lactate—Dry skin—Doxorubicin—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Ammonium lactate—Body temperature increased—Irinotecan—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Ammonium lactate—Body temperature increased—Gemcitabine—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Ammonium lactate—Rash—Sunitinib—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ammonium lactate—Dermatitis—Sunitinib—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ammonium lactate—Body temperature increased—Fluorouracil—pancreatic cancer	0.00409	0.00409	CcSEcCtD
Ammonium lactate—Infection—Docetaxel—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Ammonium lactate—Skin disorder—Docetaxel—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Ammonium lactate—Rash—Irinotecan—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Ammonium lactate—Dermatitis—Irinotecan—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Ammonium lactate—Rash—Gemcitabine—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Ammonium lactate—Dermatitis—Gemcitabine—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Ammonium lactate—Rash—Fluorouracil—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Ammonium lactate—Dermatitis—Fluorouracil—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Ammonium lactate—Pain—Docetaxel—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Ammonium lactate—Erythema—Epirubicin—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Ammonium lactate—Body temperature increased—Docetaxel—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Ammonium lactate—Erythema—Doxorubicin—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Ammonium lactate—Infection—Epirubicin—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Ammonium lactate—Skin disorder—Epirubicin—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Ammonium lactate—Rash—Docetaxel—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Ammonium lactate—Dermatitis—Docetaxel—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Ammonium lactate—Infection—Doxorubicin—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Ammonium lactate—Skin disorder—Doxorubicin—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Ammonium lactate—Pain—Epirubicin—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Ammonium lactate—Pain—Doxorubicin—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Ammonium lactate—Body temperature increased—Epirubicin—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Ammonium lactate—Body temperature increased—Doxorubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Ammonium lactate—Rash—Epirubicin—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Ammonium lactate—Dermatitis—Epirubicin—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Ammonium lactate—Rash—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Ammonium lactate—Dermatitis—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
